BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12960753)

  • 1. Interaction between polymorphisms of the dopamine D3 receptor and manganese superoxide dismutase genes in susceptibility to tardive dyskinesia.
    Zhang ZJ; Zhang XB; Hou G; Yao H; Reynolds GP
    Psychiatr Genet; 2003 Sep; 13(3):187-92. PubMed ID: 12960753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacogenetic assessment of antipsychotic-induced tardive dyskinesia: contribution of 5-hydroxytryptamine 2C receptor gene and of a combination of dopamine D3 variant allele (Gly) and MnSOD wild allele (Val)].
    Zhang Z; Hou G; Zhang X; Yao H; Sha W; Zhang X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):98-102. PubMed ID: 12673575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association analysis of the dopamine D3 receptor gene ser9gly and brain-derived neurotrophic factor gene val66met polymorphisms with antipsychotic-induced persistent tardive dyskinesia and clinical expression in Chinese schizophrenic patients.
    Liou YJ; Liao DL; Chen JY; Wang YC; Lin CC; Bai YM; Yu SC; Lin MW; Lai IC
    Neuromolecular Med; 2004; 5(3):243-51. PubMed ID: 15626824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between the Ser9Gly polymorphism of the dopamine D3 receptor gene and tardive dyskinesia in Chinese schizophrenic patients.
    Liao DL; Yeh YC; Chen HM; Chen H; Hong CJ; Tsai SJ
    Neuropsychobiology; 2001; 44(2):95-8. PubMed ID: 11490179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetics of tardive dyskinesia: combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Gly polymorphism.
    Lerer B; Segman RH; Fangerau H; Daly AK; Basile VS; Cavallaro R; Aschauer HN; McCreadie RG; Ohlraun S; Ferrier N; Masellis M; Verga M; Scharfetter J; Rietschel M; Lovlie R; Levy UH; Meltzer HY; Kennedy JL; Steen VM; Macciardi F
    Neuropsychopharmacology; 2002 Jul; 27(1):105-19. PubMed ID: 12062911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Manganese superoxide dismutase gene (MnSOD) polimorphism in schizophrenics with tardive dyskinesia from central Poland].
    Gałecki P; Pietras T; Szemraj J
    Psychiatr Pol; 2006; 40(5):937-48. PubMed ID: 17217237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between the MnSOD Ala-9Val polymorphism and development of schizophrenia and abnormal involuntary movements in the Xhosa population.
    Hitzeroth A; Niehaus DJ; Koen L; Botes WC; Deleuze JF; Warnich L
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):664-72. PubMed ID: 17291655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of the manganese superoxide dismutase gene Ala-9Val polymorphism with clinical phenotypes and tardive dyskinesia in schizophrenic patients.
    Liu H; Wang C; Chen PH; Zhang BS; Zheng YL; Zhang CX; Meng HQ; Wang Y; Chen DC; Xiu MH; Kosten TR; Zhang XY
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 May; 34(4):692-6. PubMed ID: 20346996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Additive effect between quinine oxidoreductase gene (NQO1: Pro187Ser) and manganese superoxide dismutase gene (MnSOD: Ala-9Val) polymorphisms on tardive dyskinesia in patients with schizophrenia.
    Pae CU
    Psychiatry Res; 2008 Dec; 161(3):336-8. PubMed ID: 18977034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between the serotonin 2C receptor gene and tardive dyskinesia in chronic schizophrenia: additive contribution of 5-HT2Cser and DRD3gly alleles to susceptibility.
    Segman RH; Heresco-Levy U; Finkel B; Inbar R; Neeman T; Schlafman M; Dorevitch A; Yakir A; Lerner A; Goltser T; Shelevoy A; Lerer B
    Psychopharmacology (Berl); 2000 Nov; 152(4):408-13. PubMed ID: 11140333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactive effect of cytochrome P450 17alpha-hydroxylase and dopamine D3 receptor gene polymorphisms on abnormal involuntary movements in chronic schizophrenia.
    Segman RH; Heresco-Levy U; Yakir A; Goltser T; Strous R; Greenberg DA; Lerer B
    Biol Psychiatry; 2002 Feb; 51(3):261-3. PubMed ID: 11839369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Manganese superoxide dismutase (MnSOD: Ala-9Val) gene polymorphism may not be associated with schizophrenia and tardive dyskinesia.
    Pae CU; Kim TS; Patkar AA; Kim JJ; Lee CU; Lee SJ; Jun TY; Lee C; Paik IH
    Psychiatry Res; 2007 Sep; 153(1):77-81. PubMed ID: 17582511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine D3-receptor gene variant and susceptibility to tardive dyskinesia in schizophrenic patients.
    Steen VM; Løvlie R; MacEwan T; McCreadie RG
    Mol Psychiatry; 1997 Mar; 2(2):139-45. PubMed ID: 9106238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of the Ser9Gly polymorphism in the dopamine D3 receptor gene with tardive dyskinesia in Korean schizophrenics.
    Woo SI; Kim JW; Rha E; Han SH; Hahn KH; Park CS; Sohn JW
    Psychiatry Clin Neurosci; 2002 Aug; 56(4):469-74. PubMed ID: 12109967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The increased activity of plasma manganese superoxide dismutase in tardive dyskinesia is unrelated to the Ala-9Val polymorphism.
    Zhang Z; Zhang X; Hou G; Sha W; Reynolds GP
    J Psychiatr Res; 2002; 36(5):317-24. PubMed ID: 12127599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotypic association between the dopamine D3 receptor and tardive dyskinesia in chronic schizophrenia.
    Segman R; Neeman T; Heresco-Levy U; Finkel B; Karagichev L; Schlafman M; Dorevitch A; Yakir A; Lerner A; Shelevoy A; Lerer B
    Mol Psychiatry; 1999 May; 4(3):247-53. PubMed ID: 10395214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine D3 receptor gene and tardive dyskinesia in Chinese schizophrenic patients.
    Garcia-Barceló MM; Lam LC; Ungvari GS; Lam VK; Tang WK
    J Neural Transm (Vienna); 2001; 108(6):671-7. PubMed ID: 11478419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Manganese superoxide dismutase gene polymorphism and schizophrenia: relation to tardive dyskinesia.
    Hori H; Ohmori O; Shinkai T; Kojima H; Okano C; Suzuki T; Nakamura J
    Neuropsychopharmacology; 2000 Aug; 23(2):170-7. PubMed ID: 10882843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine D3 receptor variant and tardive dyskinesia.
    Rietschel M; Krauss H; Müller DJ; Schulze TG; Knapp M; Marwinski K; Maroldt AO; Paus S; Grünhage F; Propping P; Maier W; Held T; Nöthen MM
    Eur Arch Psychiatry Clin Neurosci; 2000; 250(1):31-5. PubMed ID: 10738862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of the MscI polymorphism of the dopamine D3 receptor gene with tardive dyskinesia in schizophrenia.
    Basile VS; Masellis M; Badri F; Paterson AD; Meltzer HY; Lieberman JA; Potkin SG; Macciardi F; Kennedy JL
    Neuropsychopharmacology; 1999 Jul; 21(1):17-27. PubMed ID: 10379516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.